Characteristic
|
All patients (n = 215)
|
Primary site
|
P
|
---|
Nasal (n = 170)
|
Extra-nasal (n = 45)
|
---|
Sex
| |
0.594
|
Men
|
141 (65.6)
|
113 (66.5)
|
28 (62.2)
| |
Women
|
74 (34.4)
|
57 (33.5)
|
17 (37.8)
| |
Age (years)
|
0.404
|
≤60
|
188 (87.4)
|
147 (86.5)
|
41 (91.1)
| |
>60
|
27 (12.6)
|
23 (13.5)
|
4 (8.9)
| |
Regional lymph node involvement
|
0.150
|
Yes
|
67 (31.2)
|
49 (28.8)
|
18 (40.0)
| |
No
|
148 (68.8)
|
121 (71.2)
|
27 (60.0)
| |
“B” symptoms
| | | |
0.048
|
Yes
|
87 (40.5)
|
63 (37.1)
|
24 (53.3)
| |
No
|
128 (59.5)
|
107 (62.9)
|
21 (46.7)
| |
Elevated LDH
|
0.675
|
Yes
|
43 (20.0)
|
35 (20.6)
|
8 (17.8)
| |
No
|
172 (80.0)
|
135 (79.4)
|
37 (82.2)
| |
LTI
|
0.137
|
Yes
|
126 (58.6)
|
104 (61.2)
|
22 (48.9)
| |
No
|
89 (41.4)
|
66 (38.8)
|
23 (51.1)
| |
ECOG score
|
0.773
|
0–1
|
207 (96.3)
|
164 (96.5)
|
43 (95.6)
| |
≥2
|
8 (3.7)
|
6 (3.5)
|
2 (4.4)
| |
- All values are presented as the number of patients followed by the percentages in the parentheses
-
UADT-ENKTCL upper aerodigestive tract-extranodal natural killer/T-cell lymphoma, LDH lactate dehydrogenase, LTI local tumor invasiveness, ECOG eastern cooperative oncology group